Quera R, Núñez F P. Are we ready to use new endoscopic scores for ulcerative colitis? World J Gastroenterol 2024; 30(10): 1466-1469 [PMID: 38596489 DOI: 10.3748/wjg.v30.i10.1466]
Corresponding Author of This Article
Paulina Núñez F, MD, Assistant Professor, Digestive Disease Center, Inflammatory Bowel Disease Program, Clínica Universidad de los Andes, 2501 Plaza Avenue, Santiago 7620157, Chile. pnunez@clinicauandes.cl
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Letter to the Editor
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Mar 14, 2024; 30(10): 1466-1469 Published online Mar 14, 2024. doi: 10.3748/wjg.v30.i10.1466
Are we ready to use new endoscopic scores for ulcerative colitis?
Rodrigo Quera, Paulina Núñez F
Rodrigo Quera, Paulina Núñez F, Universidad de los Andes, Inflammatory Bowel Disease Program, Clinica Universidad de los Andes, Digestive Disease Center, Santiago 7600976, RM, Chile
Paulina Núñez F, Digestive Disease Center, Inflammatory Bowel Disease Program, Clínica Universidad de los Andes, Santiago 7620157, Chile
Paulina Núñez F, Department of Gastroenterology, Universidad de Chile-Hospital San Juan de Dios, Santiago 770123, Chile
Author contributions: Núñez F P and Quera R carried out the conception, made literature review; both authors wrote the letter, making critical revision and editing, and approved the final version.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Paulina Núñez F, MD, Assistant Professor, Digestive Disease Center, Inflammatory Bowel Disease Program, Clínica Universidad de los Andes, 2501 Plaza Avenue, Santiago 7620157, Chile. pnunez@clinicauandes.cl
Received: January 6, 2024 Peer-review started: January 6, 2024 First decision: January 16, 2024 Revised: January 23, 2024 Accepted: February 25, 2024 Article in press: February 25, 2024 Published online: March 14, 2024
Core Tip
Core Tip: For ulcerative colitis (UC), the degree of inflammatory activity can vary along the length of the colon, ranging from the rectum to the proximal colon. Currently, achieving endoscopic healing is a long-term goal in the management of UC, with the UC Endoscopic Index of Severity score and Mayo Endoscopic Subscore being the most suggested indices to evaluate this target. However, both scores only consider the most severely affected area in their final assessment. Recently, the Toronto Inflammatory Bowel Disease Global Endoscopic Reporting score has shown its usefulness in determining the extent and severity of inflammatory activity across various segments of the colon and rectum. Despite this, there is no consensus regarding the endoscopic method (total colonoscopy or sigmoidoscopy) for evaluating the achievement of endoscopic healing in UC patients.
